(Total Views: 279)
Posted On: 12/21/2021 8:35:46 AM
Post# of 101
$RIGL News Article - Fostamatinib Meets Primary Endpoint in Phase 3 Trial in Japan for Treatment of Chronic Immune Thrombocytopenia https://marketwirenews.com/news-releases/fost...08045.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
